ID: ALA4084378

Max Phase: Preclinical

Molecular Formula: C35H67N9O7

Molecular Weight: 725.98

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O

Standard InChI:  InChI=1S/C35H67N9O7/c1-5-23(4)29(33(48)42-27(35(50)51)21-22(2)3)43-31(46)25(14-7-10-18-37)40-32(47)28-16-12-20-44(28)34(49)26(15-8-11-19-38)41-30(45)24(39)13-6-9-17-36/h22-29H,5-21,36-39H2,1-4H3,(H,40,47)(H,41,45)(H,42,48)(H,43,46)(H,50,51)/t23-,24-,25-,26-,27-,28-,29-/m0/s1

Standard InChI Key:  DERXRDGTOCBBQJ-BMGWUDNWSA-N

Associated Targets(Human)

Neurotensin receptor 2 296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurotensin receptor 1 1525 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 725.98Molecular Weight (Monoisotopic): 725.5163AlogP: -0.19#Rotatable Bonds: 26
Polar Surface Area: 278.09Molecular Species: ZWITTERIONHBA: 10HBD: 9
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.08CX Basic pKa: 10.67CX LogP: -3.55CX LogD: -8.77
Aromatic Rings: 0Heavy Atoms: 51QED Weighted: 0.05Np Likeness Score: 0.13

References

1. Fanelli R, Floquet N, Besserer-Offroy É, Delort B, Vivancos M, Longpré JM, Renault P, Martinez J, Martinez J, Sarret P, Cavelier F..  (2017)  Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.,  60  (8): [PMID:28368584] [10.1021/acs.jmedchem.6b01848]

Source